ライフサイエンスコーパス: adenoviral

1 ium of Neuro-2A cells or intracellularly via adenoviral 7B2 overexpression, blocked the neurocytotoxi

2 ing levels of potency demonstrated that anti-adenoviral activity is directly correlated with HD5 bind

3 at residue 29 is a major determinant of anti-adenoviral activity, and a chemical modification that pr

4 We sought to modify adenoviral (Ad) particles by incorporating the advantage

5 We used an adenoviral (Ad) vector that encodes cyclin-dependent kin

6 We used an adenoviral (Ad) vector to overexpress IGF-II in isolated

7 For adenoviral (Ad) vector-mediated gene transfer and therap

8 aged mice were also injected with attenuated adenoviral adiponectin (Ad-Adn) or Ad-LacZ for 2 wk.

9 To increase efficiency, we administered adenoviral Apc TALENs and found that we could achieve a

10 Adenoviral B2R overexpression enhanced in vivo vascular

11 The new adenoviral-based in vitro technique did detect, however,

12 34 with or without prior vaccination with an adenoviral-based influenza vaccine.

13 We conclude that adenoviral-based studies in primary gonadotropes can ade

14 on, squirrel monkeys given ICV injections of adenoviral BDNF/noggin showed similar addition of striat

15 hat ruxolitinib-exposed mice exhibit delayed adenoviral clearance.

16 prevalence and serotype characterization of adenoviral conjunctivitis in hospital employees.

17 No healthcare-associated adenoviral conjunctivitis outbreaks occurred after algor

18 -office test can prevent the misdiagnosis of adenoviral conjunctivitis that leads to the spread of di

19 Hopkins Hospital with signs and symptoms of adenoviral conjunctivitis underwent evaluation by nurse

20 oPlus is sensitive and specific at detecting adenoviral conjunctivitis.

21 oPlus were assessed for identifying cases of adenoviral conjunctivitis.

22 then randomized to targeted injection of an adenoviral construct (10 muL; 8x10(9) plaque forming uni

23 we demonstrated that in vivo delivery of an adenoviral construct optimized for the secretion of huma

24 The adenoviral constructs contained -2871 bp, -750 bp or -23

25 In addition, adenoviral constructs were produced to identify these cr

26 e present study, injections of Cre-dependent adenoviral constructs were targeted to the ventrolateral

27 Acute ablation of Vps34 in MEFs upon adenoviral Cre infection results in a diminishment of lo

28 when a codon 12 K-Ras mutant is induced via adenoviral Cre inhalation.

29 v/Wv mice by either intrabursal injection of adenoviral Cre or inclusion of the MISR2-Cre transgene a

30 Accordingly, adenoviral Cre recombinase (AdCre)-treated LSL-Kras/Irs-

31 KRAS(G12D) in the lung by nasal delivery of adenoviral Cre recombinase (Cre), here we show that KRAS

32 Adenoviral Cre recombinase was used to delete RISP from

33 atients is modelled by confined injection of adenoviral Cre recombinase.

34 ograde pancreatic ductal injection of either adenoviral-Cre or lentiviral-Cre vectors allows titratab

35 n lung cells by intratracheal infection with adenoviral-Cre particles generated hyperplasias in all r

36 rocyte cultures where Hdac7 was deleted with adenoviral-Cre.

37 f increased prostacyclin (PGI2) derived from adenoviral cyclo-oxygenase (COX)-1/prostacyclin synthase

38 Increasing nuclear abundance of p27(kip1) by adenoviral delivery decreases the proliferative response

39 ression or downregulation was achieved using adenoviral delivery of CADM1 short hairpin RNAs or isofo

40 Tumorigenesis was triggered by intravenous adenoviral delivery of Cre recombinase in transgenic mic

41 Adenoviral delivery of GcgR to GcgR(-/-),LepR(-/-) mice

42 Adenoviral delivery of hepcidin to mice attenuates liver

43 ortality during hyperoxia, and lung-targeted adenoviral delivery of Hsp70 effectively rescues both Hs

44 e pulmonary disease airway disease utilizing adenoviral delivery of IL-1beta to determine that adapti

45 at HDACIs enhance MDA-7/IL-24 lethality, and adenoviral delivery of mda-7/IL-24 combined with tumor-s

46 thod is described to augment the efficacy of adenoviral delivery of mda-7/IL-24 in these cells.

47 Finally, adenoviral delivery of PGC-1alpha into skeletal muscle o

48 These results demonstrate that adenoviral delivery of reprogramming factors and CRISPR/

49 We have demonstrated that adenoviral delivery of the skeletal muscle Na(+) channel

50 sponse to VEGF, administered via intradermal adenoviral delivery or through systemic injection of rec

51 In this study, we designed an adenoviral delivery system to genetically modify hMPCs t

52 We used adenoviral delivery to express full-length wild type or

53 This strategy uses an adenoviral detection system that is shown to successfull

54 observed that endothelial cells responded to adenoviral DNA by phosphorylation of ATM and CHK2 and th

55 of DNA damage that can also be activated by adenoviral DNA, and on IRF1, a transcriptional regulator

56 s decreased in ApoER2(-/-) mice, and whereas adenoviral-driven apoE3 expression in wild-type mice has

57 efine a novel function of the antiapoptotic, adenoviral E1B 19K protein that may limit local host inn

58 The adenoviral E1B-55K protein prevents entry into mitosis.

59 The adenoviral E4orf3 protein facilitates exit from mitosis,

60 Thus, degradation of Tip60 by the adenoviral early proteins is important for efficient vir

61 r cells expressing MDA-7/IL-24, in which the adenoviral early region 1A (E1A) gene was driven by the

62 By use of a adenoviral eIF5A shRNA, we have achieved an effective de

63 Adenoviral expression of a constitutively active mutant

64 pharmacological inhibitor BI-D1870 or after adenoviral expression of a dominant negative RSK1 mutant

65 f ischemic skin flaps, which was reversed by adenoviral expression of ANKRD1, and delayed excisional

66 prevented in cultured human chondrocytes by adenoviral expression of catalase targeted to the mitoch

67 ion of a CF airway cell line (CF15 cells) by adenoviral expression of CFTR reduced the activation of

68 In this study, adenoviral expression of cMyBP-C(C10mut) in cultured adu

69 n and increased BK-beta1 expression, whereas adenoviral expression of MuRF1 in mouse coronary arterie

70 VEGF neutralization in mice, accomplished by adenoviral expression of soluble Flt1, resulted in 7-fol

71 in vivo attenuation of caspase activity via adenoviral expression of the biologic effector caspase i

72 Adenoviral expression of ZnT2 in lactating mouse mammary

73 d in Zmiz2(-/-) MEFs that were infected with adenoviral expression vectors for Zmiz2.

74 ng cultured neonatal rat cardiomyocytes with adenoviral gene delivery and pharmacological inhibitors,

75 hMPCs in an in vivo model, the safety of the adenoviral gene delivery was evaluated.

76 Adenoviral gene delivery was shown to be safe, with no d

77 lational block when used in combination with adenoviral gene delivery.

78 ad candidates for their capacity to increase adenoviral gene expression in an orthotopic in vivo mode

79 irst time that cationic polymers can enhance adenoviral gene expression in an orthotopic model of bla

80 o determine if cationic polymers can enhance adenoviral gene expression in cells that are difficult t

81 polymer NPGDE-1,4 Bis significantly enhanced adenoviral gene expression in the orthotopic model of bl

82 ide-based polymer paromomycin-BGDE, enhanced adenoviral gene expression within the bladder without ad

83 e similar in all groups, indicating that the adenoviral gene therapy was not associated with a higher

84 ly, further overexpression of vasohibin-1 by adenoviral gene transfer exerts multifold beneficial eff

85 The adenoviral gene transfer of human aquaporin-1 (hAQP1) wa

86 cyte canalicular expression of hAQP1 through adenoviral gene transfer promotes biliary BS output by m

87 pacing, and are amenable to patch clamp and adenoviral gene transfer techniques.

88 owing heterologous expression in myocytes by adenoviral gene transfer, wild-type telethonin became bi

89 The inactivation rate corresponding to adenoviral genome damage matched the inactivation rate o

90 E1A expression translates into inhibition of adenoviral genome replication, infectious particle produ

91 l cells against a host defense that inhibits adenoviral genome replication.

92 Nuclear delivery of the adenoviral genome requires that the capsid cross the lim

93 Adenoviral Glrx-induced sFlt in EC was inhibited by a co

94 postsynaptic GluA2-lacking AMPA receptors in adenoviral GluA1-infected CeA neurons.

95 patocytes and mouse models of transgenic and adenoviral HBV expression, we show that HBV-expressing h

96 We implanted adenoviral HCN2, AC1, or HCN2/AC1 constructs into the le

97 Recent work has shown that helper-dependent adenoviral (hdAD) vector-mediated plasma CocH reduced th

98 Furthermore, adenoviral hSCF treatment in wild-type cardiomyocytes si

99 using ROSA(mTmG);Wt1(CreER) mice showed that adenoviral hSCF treatment increased Wt1(+) lineage-deriv

100 In cultured EPDCs, adenoviral hSCF treatment significantly increased cell p

101 DC chemokine receptor ccr6 both protect from adenoviral IL-1beta-induced airway adaptive T cell immun

102 e insertion of artificial aptazymes into the adenoviral immediate early gene E1A enables small-molecu

103 tivity and PCR were employed to quantify the adenoviral inactivation rates using narrow bands of irra

104 Consistent with these findings, adenoviral-induced Pim-1 neonatal rat cardiomyocytes (NR

105 Specifically, we demonstrated that adenoviral induction of prolymphangiogenic factor VEGF-C

106 One patient died from an overwhelming adenoviral infection before reconstitution with genetica

107 humans; however, prior exposure from natural adenoviral infection can decrease such responses.

108 Adenoviral infection induced inflammatory infiltrates pr

109 Finally, using an adenoviral infection model, we show that ruxolitinib-exp

110 ed using its specific inhibitor AS1842856 or adenoviral infection of constitutively active FOXO1.

111 inducing reactive oxygen species (ROS) after adenoviral infection of mda-7/IL-24 leads to greater tra

112 Reconstitution of ANKRD1 by adenoviral infection stimulated both collagen gel contra

113 Consistent with these results, adenoviral infection with a dominant negative STAT5 muta

114 imental murine AIH (emAIH) by a self-limited adenoviral infection with the hepatic autoantigen formim

115 Using adenoviral infection, a ratiometric mitochondrially targ

116 within 24 hours of LPS injection or HSV-1 or adenoviral infection, accompanied by a predominantly neu

117 /2 phosphorylation remained unchanged during adenoviral infection, suggesting specificity of JNK acti

118 ion was induced at a magnitude comparable to adenoviral infection, suggesting that AQP1 is primarily

119 totic or a nonapoptotic death as a result of adenoviral infection.

120 es of graft failure, cytomegalovirus, and/or adenoviral infections and transplant-related mortality a

121 stream pathways mediate these Ito,f changes, adenoviral infections were used to inhibit CaMKIIdeltac,

122 ical outcome of both natural and therapeutic adenoviral infections.

123 Adenoviral injection of active TGF-beta1 into the anteri

124 receptor antagonist 7-chlorokynurenic acid, adenoviral injection of NR1 short hairpin RNA (shRNA), a

125 siRNA; affecting FGFR3-IIIb and -IIIc) or an adenoviral kinase-dead FGFR3-IIIc construct (kdFGFR3).

126 Adenoviral knockdown of CeA GluA2 subunits facilitated C

127 Adenoviral L-Fabp transduction inhibited activation of p

128 e is known about this important event in the adenoviral life cycle.

129 as applied as an imaging reporter to monitor adenoviral liver transduction with both nuclear and opti

130 safety and biologic efficacy of serotype 5, adenoviral-mediated aquaporin-1 cDNA transfer to a singl

131 y enzyme-linked immunosorbent assay, whereas adenoviral-mediated CSE overexpression in human umbilica

132 Adenoviral-mediated DAPK2 overexpression in 3T3-L1 adipo

133 inically applicable gene therapy approach by adenoviral-mediated delivery of the bicistronic vector.

134 protected from pulmonary fibrosis induced by adenoviral-mediated expression of active TGF-beta1.

135 Notably, adenoviral-mediated expression of IFT88 in mature, fully

136 eed, selective inhibition of hepatic aPKC by adenoviral-mediated expression of kinase-inactive aPKC,

137 Adenoviral-mediated expression of USP2 in the liver prom

138 Effects of vasohibin-1 overexpression by adenoviral-mediated gene transfer on angiogenesis, fibro

139 xtent similar to isoproterenol exposure, and adenoviral-mediated knockdown of Epac1 prevented isoprot

140 In this study, we show that either adenoviral-mediated or transgenic CTGF overexpression in

141 Following adenoviral-mediated overexpression of SOD2 activity (5-7

142 Increasing HO-1 expression through adenoviral-mediated overexpression or induction with cob

143 We therefore tested the effects of adenoviral-mediated overexpression or small interfering

144 mouse and rat hearts and with transgenic and adenoviral-mediated overexpression/silencing.

145 othelial monolayers, which was reversible by adenoviral-mediated PICALM transfer.

146 We show that adenoviral-mediated silencing of hepatic Fsp27 abolishes

147 e role of versican, a vitreous component, in adenoviral-mediated transgene expression was examined.

148 inase or gamma-secretase inhibitors decrease adenoviral-mediated transgene expression.

149 Adenoviral miR-33a overexpression in human or mouse isle

150 The effects of adenoviral mitofusin-2 (Ad-MFN2) overexpression were mea

151 We used our adenoviral model of memory inflation to first investigat

152 NF-kappaB activation involve infection of an adenoviral NF-kappaB-luciferase reporter into cell lines

153 We have previously shown that adenoviral or transgenic overexpression of human CD81 an

154 Adenoviral over-expression of DUSP1 inactivated MAPK pat

155 Adenoviral overexpression of ApoM in Apom(-/-) mice decr

156 Adenoviral overexpression of beta3-AR in isolated cardia

157 This reduced expression was not restored by adenoviral overexpression of BiP (immunoglobulin-binding

158 ering RNA and genetic deletion of ChREBP and adenoviral overexpression of ChREBP in rodent and human

159 Adenoviral overexpression of CLIC4 in cultured human pul

160 Hypoxia or adenoviral overexpression of constitutively activated Rh

161 d endothelial cells, metformin treatment and adenoviral overexpression of constitutively active AMPK

162 Adenoviral overexpression of CUX2 in male liver induced

163 Indeed, adenoviral overexpression of cytoplasmic SRF (SRF-DeltaN

164 on was impaired in CREBH-deficient mice, and adenoviral overexpression of FGF21 suppressed adipose ti

165 Adenoviral overexpression of GluA1 subunits in CeA accel

166 e decreased the vascular leakage compared to adenoviral overexpression of green fluorescent protein.

167 In vitro, adenoviral overexpression of miR-24 targets lacking miR-

168 Using therapeutic silencing of miR-33 and adenoviral overexpression of miR-33, we show that miR-33

169 gely non-amyloidogenic degradation products, adenoviral overexpression of MMP-9 in amyloid-prone isle

170 Importantly, adenoviral overexpression of neprilysin in islets cultur

171 Adenoviral overexpression of osteoglycin in wild-type mi

172 In osteoglycin null mice, adenoviral overexpression of osteoglycin was unable to p

173 Accordingly, adenoviral overexpression of Rab5 or D52 enhanced secret

174 In vivo adenoviral overexpression of RARbeta in the liver enhanc

175 t3 ablation sensitized mice to NASH, whereas adenoviral overexpression of Sirt3 alleviated the NASH p

176 Adenoviral overexpression of Smad2 also blocked SLPI-ind

177 Adenoviral overexpression of SMILE (Ad-SMILE) attenuated

178 We used an adenoviral overexpression strategy to show that both ful

179 Through a series of genetic silencing and adenoviral overexpression studies, we have defined GLUT1

180 h the PLD product, phosphatidic acid (PA) or adenoviral PLD1 expression in Pld1(-/-) hepatocytes, con

181 infection, since this population is naive to adenoviral preformed immunity.

182 er proteins, maturational proteolysis by the adenoviral protease leads to the differential release of

183 nhanced inactivation at low wavelengths with adenoviral protein damage at those wavelengths, adding f

184 define a new function of the antiapoptotic, adenoviral protein E1B 19K, which we have termed "apopto

185 Gam1 is an adenoviral protein, which also possesses a BC-box domain

186 This research shows UV-induced damage to adenoviral proteins across the germicidal UV spectrum at

187 is and by promoting exit from mitosis, these adenoviral proteins act to prevent the infected cell fro

188 Early adenoviral proteins, including the E1B-55K and E4orf3 pr

189 To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but se

190 Replication-competent adenoviral (RC-Ad) vectors generate exceptionally strong

191 early cytokine production is independent of adenoviral replication.

192 identified several candidates that enhanced adenoviral reporter gene expression in vitro.

193 Importantly, adenoviral rescue of C/EBPalpha in vivo ablated the hepc

194 Using gene deletion and adenoviral rescue, we demonstrate that both the GEF (CDC

195 and the immunity induced by the recombinant adenoviral RSV vaccine administered by use of an intramu

196 Human adenoviral serotype 5 (HAdV-5) vectors have predominantl

197 /-) mice, using a recombinant nonreplicating adenoviral serotype 5 vector that contained the murine M

198 Fourteen of the 44 employees had adenoviral serotypes and clinical presentation consisten

199 Importantly, acute hepatic knockdown by adenoviral shRNA targeting G9a abolishes Fgf21 repressio

200 TRAF2 knockdown with adenoviral shRNA transduction induces accumulation of de

201 Adenoviral shRNA-mediated downregulation of CeA GluA1 pr

202 ither Bmal1 deficiency or Bmal1 depletion by adenoviral shRNA.

203 ators, we depleted these co-activators using adenoviral shRNAs.

204 Finally, knockdown of DIC with adenoviral siRNA also rendered CGNs more susceptible to

205 We implanted adenoviral SkM1, HCN2, or HCN2/SkM1 constructs into left

206 ich is required for efficient cell lysis and adenoviral spread.

207 Furthermore, overexpression of miR-133b via adenoviral system in vitro led to decreased CTGF express

208 The adenoviral tetracycline (tet)-on system has not been use

209 In addition, both recombinant and adenoviral TGF-beta3 significantly promoted epithelial-t

210 r497/495 was reversed by micro-calpsiRNA and adenoviral transduced dominant negative protein kinase C

211 Adenoviral transduction allowed TIMP3 overexpression.

212 ukocytes from 112 Hispanic patients by using adenoviral transduction and 24-h culture, with quantitat

213 Adenoviral transduction of NPCs with a kinase-defective

214 In conclusion, we show that adenoviral transduction stimulates IL-33 expression in e

215 We overcame this obstacle through in vivo adenoviral transduction with matrix-targeted photoactiva

216 expressed TLR4 were created by lentiviral or adenoviral transduction.

217 3 expression was stimulated as a response to adenoviral transduction.

218 In vivo adenoviral transfection of KLF2 to the carotid bodies in

219 a chemical chaperone, phenylbutyric acid, or adenoviral transfection with ATF6 attenuated HNE-induced

220 d through transgenic overexpression of TFF2, adenoviral transfer of TFF2 or transplantation of TFF2-e

221 and prolonged following vaccination with an adenoviral vaccine encoding GP linked to Ii compared wit

222 We developed potential adenoviral vaccines that express a fusion protein of HPV

223 the lymphatic network in the defected area, adenoviral vascular endothelial growth factor C (VEGF-C)

224 clones, gene correction by helper-dependent adenoviral vector (HDAdV) or Transcription Activator-Lik

225 er vaccination with a rhesus macaque-derived adenoviral vector (simian adenovirus 7 [SAdV-7]) enhance

226 when delivered with a replication-defective adenoviral vector [Ad5-poIRF7/3(5D)].

227 rus receptor (sCAR-Fc) was expressed from an adenoviral vector and 2 short hairpin RNAs (shRdRp2.4) d

228 A vaccine platform transduced with the adenoviral vector and loaded in tandem with the recombin

229 sduction in the presence of vitreous with an adenoviral vector containing an IL-12-coding transgene i

230 An adenoviral vector containing human SPARC was used to inc

231 thway, rats were intravenously injected with adenoviral vector encoding a decoy VEGF receptor (Ad-Flk

232 ritic cells transduced with the adjuvant, an adenoviral vector encoding a dominant negative isoform o

233 Intranodally injected adenoviral VEGF-C and adenoviral vector encoding control gene LacZ induced mac

234 neural targets of the VMHdm by injecting an adenoviral vector encoding Cre recombinase (Cre)-regulat

235 lymphoblastoid cell lines transduced with an adenoviral vector expressing either LMP2 alone (n = 17)

236 genital administration of an IL-4-expressing adenoviral vector greatly increased in vivo ESC prolifer

237 Mice that expressed VEGFC from the adenoviral vector had increased lymphatic vessel density

238 er vaccination with a rhesus macaque-derived adenoviral vector in rhesus macaques enhances mucosal CD

239 The results showed that vaccination with an adenoviral vector indeed increases activation of mucosal

240 The overexpression of miR-375 with an adenoviral vector inhibited alveolar epithelial trans-di

241 that a genetically engineered RSV-F-encoding adenoviral vector provides protective immunity against R

242 of immunocompetent mice with low doses of an adenoviral vector resulted in persistent HBV infection;

243 cancer cell line (HT29) transfected with an adenoviral vector that expressed Ad VP16hLXRalpha, compa

244 This trial used a prototype adenoviral vector to express aquaporin-1 (AQP1), presuma

245 in preBotC astrocytes bilaterally (using an adenoviral vector to specifically express tetanus toxin

246 We initiated HBV infection via an adenoviral vector transferring a 1.3-fold overlength HBV

247 hese data implicate versican G1 in enhancing adenoviral vector transgene expression in a hyaluronic a

248 hanism of hyaluronan-mediated enhancement of adenoviral vector transgene expression.

249 intracerebroventricular (ICV) delivery in an adenoviral vector triggers the addition of new neurons t

250 Using an adenoviral vector, we generated mice overexpressing smad

251 Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in n

252 In earlier preclinical studies, a novel adenoviral vector-based vaccine termed AdE1-LMPpoly has

253 Adenoviral vector-mediated in vivo transduction was used

254 was overexpressed in SIRT1 LKO mice using an adenoviral vector.

255 ter vaccination with a replication-deficient adenoviral vector.

256 ially created N- and C-terminal-tagged Luman adenoviral vector.

257 by infecting cells with a p220 cDNA-encoding adenoviral vector.

258 g hydrodynamic injection or high doses of an adenoviral vector; these lead to clearance of HBV.

259 Vaccination with potent HCV adenoviral vectored vaccines fails to restore T-cell imm

260 patients were vaccinated using heterologous adenoviral vectors (ChAd3-NSmut and Ad6-NSmut) encoding

261 Recombinant adenoviral vectors (rAds) are lead vaccine candidates fo

262 Recombinant adenoviral vectors (rAds) are the most potent recombinan

263 ssed and CD63 was knocked down in mice using adenoviral vectors AdTIMP1 or AdshCD63, respectively.

264 t liver detargeting and tumor retargeting of adenoviral vectors after coating with synthetic dendrime

265 Human adenoviral vectors are being developed for use in candid

266 3, and 5 hours after injury) transduced with adenoviral vectors carrying IL8RA, IL8RB, and IL8RA/RB (

267 n astrocytes of mouse cortex by injection of adenoviral vectors containing a strong and astrocyte-spe

268 ouse corneas infected with Slurp1-expressing adenoviral vectors displayed reduced signs of inflammati

269 Adenoviral vectors encoding hepatitis C virus (HCV) nons

270 in vitro experiments with HSCs infected with adenoviral vectors encoding LacZ, Dyn2K44A, or Dyn2WT.

271 B/c (L. monocytogenes-susceptible) mice with adenoviral vectors encoding natural L. monocytogenes-der

272 ion of XBP1 was knocked down by injection of adenoviral vectors encoding small hairpin RNAs against X

273 and why this is so, we have generated potent adenoviral vectors encoding the endogenous tumor Ags (TA

274 Prophylactic vaccination with adenoviral vectors expressing either TRP-2 (Ad-Ii-TRP-2)

275 ERS-CoV infection by prior transduction with adenoviral vectors expressing the human host-cell recept

276 xpressing Cyclo-oxygenase-2 by 600-fold, and adenoviral vectors expressing the pro-apoptotic gene Bax

277 o overcome these hurdles in order to develop adenoviral vectors for combination of systemic oncolytic

278 antibodies, which can selectively immobilize adenoviral vectors for gene delivery of growth factors.

279 optimization and development of HAdV-5-based adenoviral vectors for gene therapy.

280 Adenoviral vectors have long been forerunners in the dev

281 SK-N-DZ neuroblastoma cells transduced with adenoviral vectors in the presence of versican respond w

282 Chronic central administration of MCH and adenoviral vectors increasing MCH signaling were perform

283 nd suggest that E1B 19K-deleted, replicating adenoviral vectors might induce greater inflammatory res

284 king the kappa opioid receptor (kappaOR) and adenoviral vectors overexpressing or silencing kappaOR w

285 Treatment efficacy of the adenoviral vectors released from the MMP responsive SELP

286 lymphocytic choriomeningitis virus model and adenoviral vectors to compare a vaccine expressing unmod

287 We used adenoviral vectors to express Nor-1 in normal liver (Ad/

288 lls (HUVEC) were transduced with recombinant adenoviral vectors to express wild-type, constitutively

289 Adenoviral vectors were used to express Slurp1 in cornea

290 Adenoviral vectors were used to induce transient overexp

291 CD80/86 for efficient CD8 T cell priming by adenoviral vectors.

292 9 RNA-guided nucleases, and helper-dependent adenoviral vectors.

293 ted efficiently with replication-incompetent adenoviral vectors.

294 in the evaluation of serologically distinct adenoviral vectors.

295 d have cross-reacting potential with non-Ad5 adenoviral vectors.

296 nt8a, Wnt16, and WISP1 in the synovium using adenoviral vectors.

297 Intranodally injected adenoviral VEGF-C and adenoviral vector encoding control

298 ii) ear angiogenic responses to intradermal adenoviral-VEGF injection, and iii) vascular flow recove

299 tivation profiles and binding affinities for adenoviral virus-associated RNA I (VA RNAI) and HIV-1 tr

300 Transduction of GCs with the dephospho-adenoviral-YB-1(S102A) mutant prevented the induction by